Craft

American Bio Medica

Stock Price

$0

2024-10-29

Market Capitalization

$4.8 K

2024-10-29

Revenue

$913 K

FY, 2022

American Bio Medica Summary

Company Summary

Overview
American Bio Medica Corporation is a biotechnology company that develops, manufactures and markets accurate, cost-effective immunoassay test kits, including tests for drugs of abuse. Its products are capable of accurately identifying the presence or absence of drugs in a sample within minutes. American Bio Medica test kits are used by pain management and drug treatment facilities, laboratory professionals, law enforcement and other government personnel. In addition, the company provides bulk test strip manufacturing services to unaffiliated third parties on a contract basis. 
Type
Public
Status
Active
Founded
1992
HQ
Kinderhook, NY, US | view all locations
Website
http://abmc.com/
Cybersecurity rating
Sectors

Key People

  • Melissa Waterhouse, Chief Executive Officer/ Principal Accounting and Financial Officer

    LocationsView all

    1 location detected

    • Kinderhook, NY HQ

      United States

      122 Smith Rd

    American Bio Medica Financials

    Summary Financials

    Revenue (Q1, 2023)
    $164.0K
    Gross profit (Q1, 2023)
    $74.0K
    Net income (Q1, 2023)
    $1.9M
    Cash (Q1, 2023)
    $68.0K
    EBIT (Q1, 2023)
    ($212.0K)
    Enterprise value
    $286.8K

    Footer menu